Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by MINUK, G. Y.
Right arrow Articles by MILTON, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MINUK, G. Y.
Right arrow Articles by MILTON, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 126, No. 1: 44-49
Copyright © 1987 by The Johns Hopkins University School of Hygiene and Public Health

research-article

THE NATURE OF ANTIBODY TO HEPATITIS B SURFACE ANTIGEN IN HIGH-RISK PERSONS NEGATIVE FOR OTHER HEPATITIS B VIRAL MARKERS

G. Y. MINUK1,, T. J. BOWEN2, L. SEKLA3, G. K. M. HARDING4 and L. MILTON5

1Department of Medicine, University of Calgary Calgary, Alberta, Canada
2Canadian Red Cross Blood Transfusion Service Calgary, Alberta, Canada
3Cadham Provincial Laboratories Winnipeg, Manitoba, Canada
4Department of Medical Microbiology & Infectious Diseases, University of Manitoba Winnipeg, Manitoba, Canada
5Occupational Health Department, Calgary General Hospital Calgary, Alberta, Canada

Reprint requests to Dr. G. Y. Minuk, Department of Medicine, University of Calgary, Health Sciences

Persons with antibody to hepatitis B surface antigen (anti-HBs) activity In their serum that is entirely immunoglobulin M (IgM) In nature appear not to be protected against hepatitis B virus infection. Because commercially available anti-HBs kits do not distinguish between IgM and immunoglobulin G anti-HBs activity, the question of whether or not to immunize high-risk persons with anti-HBs alone has recently been the subject of much controversy. The present study in Calgary and Winnipeg, 1984–1985, documents the nature of anti-HBs activity in sera from three groups of "high-risk" persons. Group I consisted of 26 health care employees positive for anti-HBs but negative for other hepatitis B serologic markers. Group II consisted of 26 members of high-risk ethnic populations who were also positive for anti-HBs alone. Group III consisted of 29 persons from both populations (16 health care workers and 13 members of high-risk ethnic populations) positive for both anti-HBs and antibody to hepatitis B core antigen (anti-HBc). The majority of persons in groups I and II (58% and 50%, respectively) had low levels of anti-HBs activity (sample/negative control ratio (ratio unit) < 10), as compared with only three of group III (p < 0.00001 and 0.0001, respectively). Of the remaining persons with presumably protective levels of anti-HBs (ratio unit > 10), treatment with 0.2 mM dithiothreitol, an agent that completely destroys IgM immunoglobulin activity, resulted in less inhibition of anti-HBs activity in sera from groups I and II (48.2 ± 31.1 and 51.9 ± 19.5, mean ± standard deviation, respectively) than group III sera (69.9 ± 22.0) (p < 0.05). In no case was anti-HBs activity completely eliminated following dithiothreitol treatment The results of this study indicate that anti-HBs activity in the majority of high-risk persons with presumably protective levels of anti-HBs is not exclusively IgM in nature.

antibodies; delivery of health care; hepatitis; hepatitis B; immunity; immuno-globulins


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.